Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Balchem (BCPC) EBT (2016 - 2025)

Historic EBT for Balchem (BCPC) over the last 16 years, with Q3 2025 value amounting to $52.0 million.

  • Balchem's EBT rose 1857.02% to $52.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $193.5 million, marking a year-over-year increase of 2463.54%. This contributed to the annual value of $166.5 million for FY2024, which is 2126.75% up from last year.
  • According to the latest figures from Q3 2025, Balchem's EBT is $52.0 million, which was up 1857.02% from $49.0 million recorded in Q2 2025.
  • In the past 5 years, Balchem's EBT registered a high of $52.0 million during Q3 2025, and its lowest value of $25.8 million during Q4 2022.
  • Moreover, its 5-year median value for EBT was $36.8 million (2024), whereas its average is $37.5 million.
  • Its EBT has fluctuated over the past 5 years, first crashed by 2261.76% in 2023, then skyrocketed by 3371.81% in 2024.
  • Over the past 5 years, Balchem's EBT (Quarter) stood at $33.1 million in 2021, then decreased by 22.23% to $25.8 million in 2022, then grew by 29.06% to $33.3 million in 2023, then surged by 33.72% to $44.5 million in 2024, then rose by 16.99% to $52.0 million in 2025.
  • Its EBT stands at $52.0 million for Q3 2025, versus $49.0 million for Q2 2025 and $47.9 million for Q1 2025.